<p>Global diagnostic imaging industry data book is a collection of market sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.</p> <p> </p> <p>The global <a href="https://www.grandviewresearch.com/sector-report/diagnostic-imaging-industry-data-book?utm_source=steemit&utm_medium=referral&utm_campaign=Jyoti_12Jan24_diagnostic_imaging_rd" target="_blank"><em><strong>diagnotic imaging market</strong></em></a> size was valued at <strong>USD 29.47 billion in 2022</strong> and is projected to expand at a compound annual growth rate (CAGR) of <strong>4.83%</strong> from 2023 to 2030. </p> <p> </p> <p><strong>Computed Tomography Market Growth & Trends</strong></p> <p> </p> <p>The global computed tomography market size was valued at <strong>USD 4.2 billion in 2022</strong> and is projected to expand at a compound annual growth rate (CAGR) of <strong>7.43%</strong> from 2023 to 2030. Technological advancements in CT technology, coupled with the growing prevalence of chronic disorders such as cancer, orthopedics, and cardiovascular and neurological conditions are expected to accelerate the market growth.</p> <p> </p> <p>CT scan is a most important diagnostic tool, predominantly for traumatic brain injuries and lung cancer. The prevalence of these illnesses is fostering market expansion. The growing elderly population, the prevalence of chronic diseases, the change in medical care toward image-guided interventions, and technology improvements are further market drivers. Lung cancer is one of the most frequently diagnosed cancer, according to the American Cancer Society, Inc., around 238,340 residents in the U.S. are expected to get diagnosed with lung cancer, and 127,070 deaths are estimated in 2023.</p> <p> </p> <p>Additionally, the organization has stated that 654,620 inhabitants have a history of lung cancer, among which about 80% of patients were of age 65 years or above as of January 2022. Incidences of lung cancer are predicted to rise by 38% to 2.89 million globally by 2030. A CT scan produces 3D images of the bones that aid in orthopedic surgery and improved diagnosis. Consequently, as the prevalence of orthopedic problems rises, so does the need for CT increases, leading to the market growth.</p> <p> </p> <p><strong>Magnetic Resonance Imaging Market Growth & Trends</strong></p> <p> </p> <p>The global magnetic resonance imaging market size was valued at <strong>USD 5.25 billion in 2022</strong> and is expected to expand at a <strong>CAGR of 6.81%</strong> from 2023 to 2030. Magnetic Resonance Imaging (MRI) is an efficient diagnostic machine for identifying diseases related to spine lesions, tumors, and strokes impacting the area of blood vessels and the brain. The increasing prevalence of diseases is driving the market growth.</p> <p> </p> <p>Moreover, Magnetic resonance imaging is a crucial technique to diagnose cancer/tumor and to plan treatment such as radiation therapy or surgery for cancer patients. Hence, the increasing burden of cancer is expected to fuel the MRI market globally. For instance; according to National Center for Health Statistics, in 2023, almost 1,958,310 new cancer cases and 609,820 cancer deaths are estimated to occur in the United States.</p> <p> </p> <p><strong>Nuclear Imaging Market Analysis And Forecast</strong></p> <p> </p> <p>The global nuclear imaging market size was estimated at <strong>USD 4.67 billion in 2022</strong> and is expected to grow at a compound annual growth rate (CAGR) of <strong>4.95%</strong> from 2023 to 2030. Factors such as changing preference from standalone devices to hybrid imaging modalities, growing focus on personalized medicinal treatments, advancements in the healthcare infrastructure, and rising prevalence of chronic diseases such as cardiac ailments & cancer are fueling the nuclear imaging market’s growth during the forecast period.</p> <p> </p> <p>Rising awareness levels among physicians and clinical researchers regarding the benefits of nuclear imaging coupled with increasing application areas such as cases in oncology, and neurological diseases are the factors driving PET and SPECT market. Furthermore, the increasing geriatric population and expanding horizon of applications in SPECT and PET imaging owing to constant discovery and developments of new radiopharmaceuticals are driving the diagnostic imaging market.</p> <p> </p> <p><strong><a href="https://www.grandviewresearch.com/sector-report/diagnostic-imaging-industry-data-book/request/rs1?utm_source=steemit&utm_medium=referral&utm_campaign=Jyoti_12Jan24_diagnostic_imaging_rspl" target="_blank">Order your copy of Free Sample</a> of “Diagnostic Imaging Industry Data Book - Computed Tomography, Magnetic Resonance Imaging, Nuclear Imaging, Ultrasound Device and X-ray Systems Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research</strong></p> <p> </p> <p><strong>Ultrasound Device Market Analysis And Forecast</strong></p> <p><br />The global ultrasound device market size was valued at <strong>USD 7.36 billion in 2022</strong> and is anticipated to grow at a compound annual growth rate (CAGR) of <strong>4.03%</strong> from 2023 to 2030. The rising use of ultrasound equipment for diagnostic imaging and therapy, as well as the rising prevalence of chronic and lifestyle-related illnesses are the key factors anticipated to drive the market’s growth. Additionally, technological advancements in ultrasound devices, and rising demand for minimally invasive surgeries are expected to create lucrative growth opportunities.</p> <p> </p> <p>Ultrasound technology is used in various application areas such as cardiology, obstetrics/ gynecology, vascular, orthopedic, and general imaging. The rising prevalence of cardiac disorders is expected to boost the ultrasound device market globally. According to WHO, Cardiovascular diseases (CVDs) are the major cause of death globally, taking approximately 17.9 million lives each year. Additionally, as per the Centers for Disease Control & Prevention, in the United States, every year about 805,000 people have a heart attack and about 1 in 20 adults age 20 and older have Coronary Artery Disease (about 5%).</p> <p> </p> <p><strong>X-ray Systems Market Analysis And Forecast</strong></p> <p><br />The global x-ray systems market size was valued at <strong>USD 7.89 billion in 2022</strong> and is anticipated to expand at a compound annual growth rate (CAGR) of <strong>2.28%</strong> from 2023 to 2030. Rising demand for early disease diagnosis, constant technological advances, increase in product development, favorable healthcare funding, and rising government investments in developing countries are expected to fuel the market growth.</p> <p> </p> <p>Additionally, the rising geriatric population and growing prevalence of orthopedic trauma due to severe accidents are some of the inevitable factors supporting the market’s growth. According to United Nations, the number of people aged 65 years or above is expected to reach 1.6 billion in 2050, accounting for more than 16% of the global population. The geriatric population is prone to develop conditions such as arthritis, osteoporosis, and bone fractures. According to the Centers for Disease Control and Prevention, around 23.7% or nearly 58.5 million inhabitants are diagnosed with arthritis. More women (23.5%) are predominantly suffering from the disease compared to men (18.1%).</p>
Get a variety of reliable diagnostic strips like fluoro touch, tear-touch, and tear-touch blu. Their all types of equipment are CE-certified. Madhu Instruments ensures the packaging quality so that all products remain safe to use. Visit https://www.madhuinstruments.com/product-category/diagnostic-strips for more!
<p>Diagnostic Imaging Industry Data Book Covers Computed Tomography, Magnetic Resonance Imaging, Nuclear Imaging, Ultrasound Device and X-ray Systems Markets.</p> <p><br />Grand View Research’s diagnostic imaging industry data book is a collection of market sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.</p> <p> </p> <p><strong><a href="https://www.grandviewresearch.com/sector-report/diagnostic-imaging-industry-data-book?utm_source=steemit&utm_medium=referral&utm_campaign=Jyoti_18Aug23_diagnostic_imaging_rd" target="_blank">Access the Global Diagnostic Imaging Industry Data Book, 2023 to 2030</a>, compiled with details like market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking, macro-environmental analyses, and regulatory & technological framework studies.</strong></p> <p> </p> <p><br /><strong>Computed Tomography Market Growth & Trends</strong></p> <p> </p> <p><br />The global computed tomography market size is expected to reach USD 7,551.7 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.3% from 2022 to 2030. The increasing burden of chronic disorders, such as cardiovascular diseases and cancer, and the high demand for effective imaging tools are the factors driving growth. According to the International Agency for Cancer on Research, in 2020 globally there were about 19,292,789 new cancer cases with 9,958,133 deaths. The same source stated that the prevalence of cancer is predicted to increase to 50,550,287 by 2025. In addition, increasing demand for computed tomography (CT) systems in emergency care departments are expected to be a major driver during the forecast period.</p> <p><br />Advanced technology with features such as dose management systems, the ability to diagnose tumors through motion (4D), artificial intelligence integration, and high-end material differentiation is expected to replace the existing conventional devices. In September 2021, GE Healthcare introduced the Revolution Ascend CT system, the technology that combines artificial intelligence (AI) to improve operational efficiency and patient comfort. The increasing number of favorable reimbursement policies by the government as well as private entities are also expected to drive the market at a lucrative pace. Growing demand for ambulatory diagnostic centers due to improving affordability and increasing reach of CT scanners to remote regions is expected to aid further growth.</p> <p> </p> <p><strong>Magnetic Resonance Imaging Market Growth & Trends</strong></p> <p><br />The global magnetic resonance imaging market size is expected to reach USD 9.1 billion by 2030, registering a CAGR of 6.8% from 2023 to 2030, according to a new report by Grand View Research, Inc. The growing prevalence of chronic diseases and increasing demand for early diagnostic techniques are the factors expected to drive the market growth.<br />In addition, the growing adoption of less invasive procedures is also contributing to the growth of the market. Moreover, the growing number of clinical trials to understand the effectiveness and efficiency of MRI machines in various clinical applications is also expected to boost the market growth. End-users such as research institutes and universities are frequently studying the efficiency of MRI devices with high field strength such as 7T, 10T, and 10.5T.</p> <p> </p> <p><strong><a href="https://www.grandviewresearch.com/sector-report/diagnostic-imaging-industry-data-book/request/rs1?utm_source=steemit&utm_medium=referral&utm_campaign=Jyoti_18Aug23_diagnostic_imaging_rspl" target="_blank">Order your copy of Free Sample</a> of “Diagnostic Imaging Industry Data Book - Computed Tomography, Magnetic Resonance Imaging, Nuclear Imaging, Ultrasound Device and X-ray Systems Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research</strong></p> <p> </p> <p><br /><strong>Ultrasound Device Market Growth & Trends</strong></p> <p><br />The global ultrasound device market size is expected to reach USD 14.5 billion by 2030, registering a CAGR of 4.3% over the forecast period, according to a new report by Grand View Research, Inc. Ultrasound is a very efficient technology that aids in the diagnosis of various disorders such as tumors as well as the detection of changes in the appearance of organs, tissues, and arteries. It also has a range of therapeutic applications. An increase in the adoption of ultrasound devices for diagnosis and treatment is driving the market. In addition, a rise in the adoption of minimally invasive surgeries, coupled with technological advancements is expected to boost the market growth.</p> <p><br />Emerging innovations in ultrasound technology are expanding the market size. Hand-held ultrasound devices have made the technology more accessible for use in limited-resource communities around the world. Furthermore, the introduction of 3D/4D ultrasound and the integration of artificial intelligence (Al) to automate time-consuming processes are expected to propel the market growth during the forecast period. For instance, in September 2020, GE Healthcare launched Voluson SWIFT, a new ultrasound technology, which is designed to help women’s health by allowing clinicians to enhance patient outcomes by expanding diagnostic capabilities. The system includes industry-first AI algorithms for auto-recognition and has excellent image quality.</p> <p> </p> <p><strong>X-ray Systems Market Growth & Trends</strong></p> <p><br />The global x-ray systems market size is expected to reach USD 9.4 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 2.3% from 2022 to 2030. Technological advancements in the healthcare sector and supportive investments by the government are driving the market. In addition, increase in the demand for early-stage diagnosis of chronic diseases and screening programs are expected to boost market growth.</p> <p><br />Emerging innovations in the x-ray systems is expanding the market size, such as integration of Artificial Intelligence (AI) in medical imaging systems, robotic, and mobile x-ray systems have made the technology more accessible for use in limited-resource communities around the world. For instance, in March 2021, Philips healthcare announced partnership with Lunit, a leading medical AI startup, with this collaboration Lunit’s INSIGHT CXR chest detection suite will be incorporated into Philips diagnostic x-ray suite, to achieve better patient outcomes, improve the experience of patients and staff, and lower the cost of care.</p> <p><br />The rising prevalence and awareness of chronic diseases like cancer, neurological conditions, orthopedics and cardiovascular diseases, which demands the adoption of x-ray systems for diagnosis are expected to expand the market during forecast period. Furthermore, the growing adoption of Digital Radiography (DR) is expected to boost the market growth as DR systems produces, high contrast resolution images at a lower ionizing radiation.</p> <p> </p> <p><strong>Go through <a href="https://www.grandviewresearch.com/sector-report/diagnostic-imaging-industry-data-book/toc" target="_blank">the table of content of Diagnostic Imaging Industry Data Book</a> to get a better understanding of the Coverage & Scope of the study.</strong></p> <p> </p> <p><strong>About Grand View Research</strong></p> <p><br />Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.</p> <p> </p> <p> </p>
Madhu Instruments is the reliable diagnostic strips manufacturers of the country. It offers you best quality and wide range of sodium ophthalmic and tear touch strips. They offer products at highly affordable and recommended by top doctors and surgeons.
|āĻāĻ¸āĻ¸āĻžāĻ˛āĻžāĻŽā§ āĻāĻ˛āĻžāĻāĻā§āĻŽ| |---| **āĻŦāĻŋāĻ¸āĻŽāĻŋāĻ˛ā§āĻ˛āĻžāĻšāĻŋāĻ° āĻ°āĻžāĻšāĻŽāĻžāĻ¨āĻŋāĻ° āĻ°āĻšā§āĻŽāĨ¤** ***āĻāĻŽāĻŋ āĻāĻāĻŋāĻā§āĻ˛ āĻŽāĻŋā§āĻžāĨ¤*** ***āĻŦāĻžāĻāĻ˛āĻž āĻŦā§āĻ˛āĻā§āĻ° āĻāĻāĻāĻ¨ āĻ¨āĻŋā§āĻŽāĻŋāĻ¤ āĻŦā§āĻ˛āĻāĻžāĻ°āĨ¤*** ***āĻŦāĻžāĻāĻ˛āĻž āĻāĻžāĻˇāĻž āĻāĻŽāĻžāĻ° āĻĒā§āĻ°āĻžāĻŖā§āĻ° āĻāĻžāĻˇāĻžāĨ¤*** ***āĻāĻžāĻ˛ā§āĻŦāĻžāĻ¸āĻŋ āĻŦāĻžāĻāĻ˛āĻž āĻŦā§āĻ˛āĻāĻā§āĨ¤*** <div class=text-justify>āĻā§āĻŽāĻ¨ āĻāĻā§āĻ¨ āĻŦāĻ¨ā§āĻ§ā§āĻ°āĻž? āĻŦāĻ¨ā§āĻ§ā§āĻ°āĻž, āĻāĻļāĻž āĻāĻ°āĻŋ āĻ¸āĻŦāĻžāĻ āĻāĻžāĻ˛ā§ āĻāĻā§āĻ¨āĨ¤ āĻāĻŽāĻŋ āĻ āĻāĻžāĻ˛ā§ āĻāĻāĻŋ āĻāĻ˛āĻšāĻžāĻŽāĻĻā§āĻ˛āĻŋāĻ˛ā§āĻ˛āĻžāĻšāĨ¤ āĻŦāĻ¨ā§āĻ§ā§āĻ°āĻž, āĻāĻāĻā§ āĻāĻŽāĻŋ āĻ¸āĻŽā§āĻĒā§āĻ°ā§āĻŖ āĻāĻŋāĻ¨ā§āĻ¨ āĻ§āĻ°āĻ¨ā§āĻ° āĻāĻāĻāĻž āĻĒā§āĻ¸ā§āĻ āĻ¨āĻŋā§ā§ āĻāĻĒāĻ¸ā§āĻĨāĻŋāĻ¤ āĻšā§ā§āĻāĻŋāĨ¤ āĻŦāĻ¨ā§āĻ§ā§āĻ°āĻž, āĻāĻŽāĻŋ āĻāĻŽāĻžāĻ° āĻŽāĻžāĻā§ āĻ¨āĻŋā§ā§ āĻāĻāĻā§ āĻāĻŦāĻ¨ā§ āĻ¸āĻŋāĻ¨āĻž āĻĄāĻžā§āĻžāĻāĻ¨āĻ¸ā§āĻāĻŋāĻ āĻāĻ¨ā§āĻĄ āĻāĻ¨āĻ¸āĻžāĻ˛āĻā§āĻ¨ā§āĻ āĻ¸ā§āĻ¨ā§āĻāĻžāĻ°ā§ āĻāĻŋā§ā§āĻāĻŋāĻ˛āĻžāĻŽ āĻĄāĻžāĻā§āĻ¤āĻžāĻ°ā§āĻ° āĻāĻžāĻā§ āĻāĻŦāĻ āĻ¸ā§āĻ āĻ āĻāĻŋāĻā§āĻāĻ¤āĻžāĻāĻžāĻ āĻāĻŽāĻžāĻ° āĻŦāĻžāĻāĻ˛āĻž āĻŦā§āĻ˛āĻā§āĻ° āĻ¸āĻŦāĻžāĻ° āĻ¸āĻžāĻĨā§ āĻļā§ā§āĻžāĻ° āĻāĻ°āĻ¤ā§ āĻ¯āĻžāĻā§āĻāĻŋāĨ¤ āĻāĻ˛ā§āĻ¨ āĻ¤āĻžāĻšāĻ˛ā§ āĻļā§āĻ°ā§ āĻāĻ°āĻž āĻ¯āĻžāĻ- <br>āĻāĻŽāĻžāĻ° āĻŦāĻžāĻ¸āĻž āĻŽāĻŋāĻ°āĻĒā§āĻ° āĻĻā§āĻ āĻ¨āĻžāĻŽā§āĻŦāĻžāĻ°ā§āĻ° āĻāĻāĻ āĻŦā§āĻ˛āĻā§āĻ° āĻā§ āĻ¨āĻžāĻŽā§āĻŦāĻžāĻ° āĻ°ā§āĻĄā§āĨ¤ āĻāĻŽāĻžāĻ° āĻŦāĻžāĻ¸āĻž āĻĨā§āĻā§ āĻļāĻŋā§āĻžāĻ˛ āĻŦāĻžā§āĻŋ āĻāĻŦāĻ¨ā§ āĻ¸āĻŋāĻ¨āĻž āĻĄāĻžā§āĻžāĻāĻ¨āĻ¸ā§āĻāĻŋāĻ āĻāĻ¨ā§āĻĄ āĻāĻ¨āĻ¸āĻžāĻ˛āĻā§āĻ¨ā§āĻ āĻ¸ā§āĻ¨ā§āĻāĻžāĻ°ā§ āĻ¯ā§āĻ¤ā§ āĻ°āĻŋāĻāĻļāĻž āĻāĻžā§āĻž āĻ˛āĻžāĻā§ ā§¨ā§Ļ āĻāĻžāĻāĻž, āĻāĻ° āĻšā§āĻāĻā§ āĻ¯ā§āĻ¤ā§ āĻ˛āĻžāĻā§ āĻŽāĻžāĻ¤ā§āĻ° ā§Ģ āĻŽāĻŋāĻ¨āĻŋāĻāĨ¤ āĻ¯ā§āĻšā§āĻ¤ā§ āĻŽāĻž āĻŦā§āĻĻā§āĻ§ āĻŽāĻžāĻ¨ā§āĻˇ āĻ¤āĻžāĻ āĻŽāĻžāĻā§ āĻ¨āĻŋā§ā§ āĻāĻŽāĻŋ āĻ°āĻŋāĻāĻļāĻžā§ āĻāĻ°ā§āĻ āĻāĻŋā§ā§āĻāĻŋāĻ˛āĻžāĻŽāĨ¤ || |---| |***āĻāĻŋāĻ¤ā§āĻ°āĻ āĻāĻŦāĻ¨ā§ āĻ¸āĻŋāĻ¨āĻž āĻĄāĻžā§āĻžāĻāĻ¨āĻ¸ā§āĻāĻŋāĻ āĻāĻ¨ā§āĻĄ āĻāĻ¨āĻ¸āĻžāĻ˛āĻā§āĻ¨ā§āĻ āĻ¸ā§āĻ¨ā§āĻāĻžāĻ°, āĻŽāĻŋāĻ°āĻĒā§āĻ°āĨ¤***| <i>āĻāĻŽāĻžāĻ° āĻŽāĻž āĻŽāĻžāĻĻāĻžāĻ°ā§āĻĒā§āĻ°ā§ āĻā§āĻ°āĻžāĻŽā§āĻ° āĻŦāĻžā§āĻŋāĻ¤ā§ āĻĨāĻžāĻā§āĨ¤ āĻŦā§āĻ¸ ā§ā§Ģ āĻŦāĻāĻ°āĨ¤ āĻŦāĻžāĻŦāĻž āĻŽāĻžāĻ°āĻž āĻā§āĻā§āĻ¨ āĻĒā§āĻ°āĻžā§ ā§Ēā§Ļ āĻŦāĻāĻ°ā§āĻ° āĻāĻžāĻāĻžāĻāĻžāĻāĻŋāĨ¤ āĻŽāĻž āĻŦāĻžā§āĻŋāĻ¤ā§ āĻāĻāĻžāĻ āĻĨāĻžāĻā§āĻ¨āĨ¤ āĻ¯ā§āĻšā§āĻ¤ā§ āĻŦā§āĻ¸ā§āĻ āĻŽāĻžāĻ¨ā§āĻˇ āĻ¸ā§ āĻāĻžāĻ°āĻŖā§ āĻŽāĻžāĻā§ āĻŽāĻžāĻā§āĻ āĻ āĻ¸ā§āĻ¸ā§āĻĨ āĻšā§ā§ āĻĒā§ā§āĻ¨ āĻāĻŋāĻ¨ā§āĻ¤ā§ āĻ¸āĻšāĻā§ āĻĄāĻžāĻā§āĻ¤āĻžāĻ°ā§āĻ° āĻāĻžāĻā§ āĻ¯ā§āĻ¤ā§ āĻāĻžāĻ¨ āĻ¨āĻžāĨ¤ āĻāĻŋāĻ¨ā§āĻ¤ā§ āĻ¯āĻāĻ¨ āĻā§āĻŦ āĻŦā§āĻļāĻŋ āĻ āĻ¸ā§āĻ¸ā§āĻĨ āĻšā§ā§ āĻĒā§ā§āĻ¨ āĻ¤āĻāĻ¨ āĻ¨āĻŋāĻā§ āĻāĻā§āĻā§ āĻāĻ°ā§āĻ āĻŦāĻ˛ā§āĻ¨ āĻ¯ā§, āĻāĻŽāĻžāĻā§ āĻĄāĻžāĻā§āĻ¤āĻžāĻ°ā§āĻ° āĻāĻžāĻā§ āĻ¨āĻŋā§ā§ āĻ¯āĻžāĨ¤ āĻ˛āĻžāĻ¸ā§āĻ āĻ¯āĻāĻ¨ āĻ āĻ¸ā§āĻ¸ā§āĻĨ āĻšā§ā§ āĻĒā§ā§āĻāĻŋāĻ˛ā§āĻ¨ āĻ¤āĻāĻ¨ āĻŦāĻžā§āĻŋāĻ¤ā§ āĻŽāĻžāĻ¨ā§ āĻāĻŽāĻžāĻĻā§āĻ° āĻ¯ā§ āĻāĻ°āĻāĻž āĻāĻā§ āĻ¸ā§āĻ āĻāĻ°ā§ āĻŽāĻž āĻāĻāĻžāĻ āĻāĻŋāĻ˛ā§āĻ¨āĨ¤ āĻŦāĻžā§āĻŋāĻ¤ā§ āĻ āĻŦāĻļā§āĻ¯ āĻŦā§ āĻāĻžāĻ āĻĨāĻžāĻā§āĻ¨, āĻĨāĻžāĻāĻ˛ā§ āĻāĻŋ āĻšāĻŦā§, āĻ¸ā§ āĻĨāĻžāĻā§ āĻāĻ˛āĻžāĻĻāĻž āĻāĻ°ā§āĨ¤ āĻ¤ā§ āĻāĻāĻŦāĻžāĻ° āĻŽāĻž āĻ¯āĻāĻ¨ āĻāĻāĻž āĻāĻ°ā§ āĻ āĻ¸ā§āĻ¸ā§āĻĨ āĻšā§ā§ āĻĒā§ā§āĻāĻŋāĻ˛ā§āĻ¨ āĻ¤āĻāĻ¨ āĻŽāĻž āĻ¨āĻžāĻāĻŋ āĻ°āĻžāĻ¤ā§ āĻ āĻ¨ā§āĻāĻŦāĻžāĻ° āĻŦā§ āĻāĻžāĻāĻā§ āĻĄā§āĻā§āĻāĻŋāĻ˛ āĻāĻŋāĻ¨ā§āĻ¤ā§ āĻļā§āĻ¨ā§āĻ¨ āĻ¨āĻŋāĨ¤ || |----| |***āĻāĻŋāĻ¤ā§āĻ°āĻ āĻšāĻžāĻ¸āĻĒāĻžāĻ¤āĻžāĻ˛ā§āĻ° āĻĒā§āĻ°āĻŦā§āĻļāĻĻā§āĻŦāĻžāĻ°āĨ¤***| āĻ¸āĻāĻžāĻ˛ āĻŦā§āĻ˛āĻžā§ āĻ āĻāĻŦāĻ° āĻ¨ā§ā§ āĻ¨āĻŋ, āĻ¯ā§ āĻŽāĻžā§ā§āĻ° āĻāĻŋ āĻ āĻŦāĻ¸ā§āĻĨāĻžāĨ¤ āĻ¸āĻāĻžāĻ˛ā§ āĻāĻŽāĻŋ āĻ¯āĻāĻ¨ āĻĸāĻžāĻāĻž āĻĨā§āĻā§ āĻŽāĻžāĻā§ āĻĢā§āĻ¨ āĻĻāĻŋāĻ˛āĻžāĻŽ āĻ¤āĻāĻ¨ āĻŽāĻž āĻāĻĨāĻž āĻŦāĻ˛āĻ¤ā§ āĻĒāĻžāĻ°āĻāĻŋāĻ˛ā§āĻ¨ āĻ¨āĻžāĨ¤ āĻāĻŽāĻŋ āĻ¤āĻāĻ¨ āĻāĻŋāĻā§āĻā§āĻ¸ āĻāĻ°āĻ˛āĻžāĻŽ āĻāĻŋ āĻ āĻŦāĻ¸ā§āĻĨāĻž āĻāĻĒāĻ¨āĻžāĻ°? āĻ¤āĻāĻ¨ āĻŽāĻž āĻāĻŽāĻžāĻā§ āĻŦāĻ˛ā§ āĻ¯ā§, āĻ¤āĻžāĻ° āĻ āĻŦāĻ¸ā§āĻĨāĻž āĻā§āĻŦāĻ āĻāĻžāĻ°āĻžāĻĒāĨ¤ āĻ¤āĻāĻ¨ āĻāĻŽāĻŋ āĻāĻŽāĻžāĻ° āĻā§āĻ āĻŦā§āĻ¨ā§āĻ° āĻāĻžāĻā§ āĻĢā§āĻ¨ āĻĻāĻŋā§ā§ āĻŦāĻ˛āĻŋ āĻ¤ā§āĻ āĻāĻāĻ¨āĻŋ āĻŽāĻžāĻā§ āĻ¤ā§āĻ° āĻŦāĻžā§āĻŋāĻ¤ā§ āĻ¨āĻŋā§ā§ āĻĄāĻžāĻā§āĻ¤āĻžāĻ° āĻĻā§āĻāĻžāĨ¤ āĻāĻ°āĻĒāĻ° āĻā§āĻ āĻāĻĒā§ āĻāĻ āĻāĻ¨ā§āĻāĻžāĻ° āĻŽāĻ§ā§āĻ¯ā§ āĻāĻ¸ā§ āĻŽāĻžāĻā§ āĻāĻ° āĻŦāĻžā§āĻŋāĻ¤ā§ āĻ¨āĻŋā§ā§ āĻ¯āĻžā§ āĻāĻŦāĻ āĻĒā§āĻ°āĻžāĻĨāĻŽāĻŋāĻ āĻāĻŋāĻāĻŋā§āĻ¸āĻž āĻĻāĻŋā§ā§ āĻāĻˇāĻ§ āĻ¨āĻŋā§ā§ āĻ¨ā§ā§āĨ¤ āĻŽāĻžā§ā§āĻ° āĻ¸āĻŽāĻ¸ā§āĻ¯āĻž āĻšāĻā§āĻā§, āĻ¤āĻžāĻ° āĻŽāĻžāĻĨāĻž āĻāĻŦāĻ āĻāĻžāĻ¨ āĻ¸āĻš āĻāĻŋāĻ˛āĻŋāĻ āĻŽā§āĻ°ā§ āĻŦā§āĻ¯āĻžāĻĨāĻž āĻšā§ āĻāĻŦāĻ āĻ¸ā§āĻāĻž āĻĒā§āĻ°āĻžā§ āĻ¸āĻŦ āĻ¸āĻŽā§āĻ āĻšā§āĨ¤ āĻāĻ°āĻĒāĻ° āĻāĻŽāĻŋ āĻāĻāĻĻāĻŋāĻ¨ āĻŦāĻžā§āĻŋāĻ¤ā§ āĻāĻŋā§ā§ āĻŽāĻžāĻā§ āĻĸāĻžāĻāĻžā§ āĻ¨āĻŋā§ā§ āĻāĻ¸āĻŋ āĻĄāĻžāĻā§āĻ¤āĻžāĻ° āĻĻā§āĻāĻžāĻ¨ā§āĻ° āĻāĻ¨ā§āĻ¯āĨ¤ ā§Ž āĻ āĻ āĻā§āĻā§āĻŦāĻ° ā§¨ā§Ļā§¨ā§¨ āĻ¤āĻžāĻ°āĻŋāĻā§ āĻŽāĻžāĻā§ āĻŽāĻŋāĻ°āĻĒā§āĻ° āĻļāĻŋā§āĻžāĻ˛āĻŦ āĻāĻŦāĻ¨ā§ āĻ¸āĻŋāĻ¨āĻž āĻĄāĻžā§āĻžāĻāĻ¨āĻ¸ā§āĻ¸āĻ˛āĻā§āĻ¨ā§āĻ āĻ āĻĄāĻžāĻā§āĻ¤āĻžāĻ° āĻŽā§āĻŽā§āĻ¨ āĻ¸āĻžāĻšā§āĻŦā§āĻ° āĻāĻžāĻā§ āĻ¨āĻŋā§ā§ āĻ¯āĻžāĻā§āĻž āĻšā§āĨ¤ āĻ¤āĻāĻ¨ āĻ āĻŦāĻļā§āĻ¯ āĻāĻŽāĻžāĻ° āĻā§āĻžāĻāĻĢ āĻŽāĻžāĻā§ āĻĄāĻžāĻā§āĻ¤āĻžāĻ°ā§āĻ° āĻāĻžāĻā§ āĻ¨āĻŋā§ā§ āĻāĻŋā§ā§āĻāĻŋāĻ˛ āĻ¯āĻžāĻ° āĻāĻžāĻ°āĻŖā§ āĻ¸ā§āĻŦāĻžāĻ° āĻāĻŽāĻŋ āĻĒā§āĻ¸ā§āĻāĻāĻŋ āĻāĻ°āĻ¤ā§ āĻĒāĻžāĻ°āĻŋāĻ¨āĻŋāĨ¤ || |---| |***āĻāĻŋāĻ¤ā§āĻ°āĻ āĻĢā§āĻ˛ā§āĻ° āĻāĻŋāĻ¤ā§āĻ¤āĻŋāĻ āĻ¸ā§āĻŦāĻž āĻ¨āĻŋāĻ°ā§āĻĻā§āĻļāĻŋāĻāĻžāĨ¤***| āĻ¸ā§āĻĻāĻŋāĻ¨ āĻĄāĻžāĻā§āĻ¤āĻžāĻ° āĻ¸āĻŋāĻāĻŋ āĻ¸ā§āĻāĻžāĻ¨ āĻāĻŦāĻ āĻāĻ° āĻ āĻā§ā§āĻāĻāĻŋ āĻĒāĻ°ā§āĻā§āĻˇāĻž āĻĻā§ā§ āĻāĻŦāĻ āĻĒāĻ°ā§āĻā§āĻˇāĻž āĻāĻ°āĻžāĻ° āĻĒāĻ°ā§ āĻāĻžāĻ¨āĻ¤ā§ āĻĒāĻžāĻ°āĻ˛āĻžāĻŽ āĻ¯ā§, āĻŽāĻž āĻā§āĻ āĻā§āĻ āĻā§ā§āĻāĻāĻŋ āĻ¸ā§āĻā§āĻ āĻāĻ°ā§āĻāĻŋāĻ˛, āĻāĻ° āĻāĻā§ āĻ āĻŦāĻļā§āĻ¯ āĻŦā§ āĻāĻāĻāĻž āĻ¸ā§āĻāĻ āĻāĻ°ā§āĻāĻŋāĻ˛ ā§¨ā§Ļā§¨ā§§ āĻ¸āĻžāĻ˛ā§āĻ° āĻā§āĻ˛āĻžāĻ āĻŽāĻžāĻ¸ā§āĨ¤ āĻ¤āĻāĻ¨ āĻŽāĻŋāĻ°āĻĒā§āĻ°ā§ āĻāĻ˛ā§āĻ āĻšāĻžāĻ¸āĻĒāĻžāĻ¤āĻžāĻ˛ā§ āĻāĻŋāĻāĻŋā§āĻ¸āĻž āĻāĻ°āĻŋā§ā§āĻāĻŋāĻ˛āĻžāĻŽāĨ¤ || |--| |**āĻāĻŋāĻ¤ā§āĻ°āĻ āĻšāĻžāĻ¸āĻĒāĻžāĻ¤āĻžāĻ˛ā§ āĻŽāĻž āĻāĻŦāĻ āĻāĻŽāĻŋāĨ¤**| āĻāĻāĻŽāĻžāĻ¸ āĻĒāĻ°ā§ āĻāĻāĻā§ āĻāĻŦāĻžāĻ° āĻāĻŽāĻŋ āĻŽāĻžāĻā§ āĻāĻŦāĻ¨ā§ āĻ¸āĻŋāĻ¨āĻžā§ āĻ¨āĻŋā§ā§ āĻā§āĻ˛āĻžāĻŽāĨ¤ āĻĄāĻžāĻā§āĻ¤āĻžāĻ° āĻĒā§āĻ°ā§āĻ¸āĻžāĻ° āĻŽā§āĻĒā§ āĻĻā§āĻāĻ˛ā§āĻ¨ āĻŽāĻžā§ā§āĻ° āĻĒā§āĻ°ā§āĻ¸āĻžāĻ° ā§Žā§Ļ/ā§§ā§ā§ĻāĨ¤ āĻĄāĻžāĻā§āĻ¤āĻžāĻ° āĻŽāĻžāĻā§ āĻ āĻ¨ā§āĻ āĻļāĻžāĻ¸āĻžāĻ˛ā§āĻ¨ āĻāĻžāĻ°āĻŖ, āĻŽāĻž āĻ¨āĻžāĻāĻŋ āĻāĻā§āĻ° āĻŦāĻžāĻ° āĻ¤āĻžāĻ° āĻĒā§āĻ°ā§āĻ¸āĻžāĻ°ā§āĻ° āĻāĻĨāĻž āĻŦāĻ˛ā§āĻ¨ āĻ¨āĻŋāĨ¤ āĻĄāĻžāĻā§āĻ¤āĻžāĻ° āĻāĻŦāĻžāĻ° āĻŽāĻžāĻā§ āĻĒā§āĻ°ā§āĻ¸āĻžāĻ°ā§āĻ° āĻāĻˇāĻ§ āĻ˛āĻŋāĻā§ āĻĻāĻŋāĻ˛ā§āĻ¨ āĻāĻŦāĻ āĻŦāĻ˛āĻ˛ā§āĻ¨ āĻ¯ā§ āĻāĻ āĻŦā§āĻ˛āĻž āĻ¨āĻž āĻā§ā§ā§ āĻĨāĻžāĻāĻ˛ā§ āĻ¸āĻŽāĻ¸ā§āĻ¯āĻž āĻ¨āĻžāĻ āĻāĻŋāĻ¨ā§āĻ¤ā§ āĻĒā§āĻ°ā§āĻ¸āĻžāĻ°ā§āĻ° āĻāĻˇāĻ§ āĻ¨āĻž āĻā§ā§ā§ āĻĨāĻžāĻāĻž āĻ¯āĻžāĻŦā§ āĻ¨āĻžāĨ¤ āĻāĻŦāĻžāĻ° āĻĻā§ā§ āĻŽāĻžāĻ¸ āĻĒāĻ°ā§ āĻāĻ¸āĻ¤ā§ āĻŦāĻ˛ā§āĻā§āĻ¨āĨ¤ āĻ¤āĻžāĻ°āĻĒāĻ° āĻĄāĻžāĻā§āĻ¤āĻžāĻ°ā§āĻ° āĻĻā§āĻā§āĻž āĻĒā§āĻ°ā§āĻ¸āĻā§āĻ°āĻŋāĻĒāĻļāĻ¨ āĻĻā§āĻāĻŋā§ā§ āĻāĻŽāĻŋ āĻāĻˇāĻ§ āĻāĻŋāĻ¨ā§ āĻŽāĻžāĻā§ āĻ¨āĻŋā§ā§ āĻŦāĻžāĻ¸āĻžā§ āĻĢāĻŋāĻ°āĻ˛āĻžāĻŽāĨ¤ || |---| |**āĻāĻŋāĻ¤ā§āĻ°āĻ āĻĢāĻžāĻ°ā§āĻŽā§āĻ¸āĻŋāĻ¤ āĻāĻˇāĻ§ āĻā§āĻ¨āĻžāĻ° āĻ¸āĻŽā§āĨ¤**| āĻŽā§āĻ˛āĻ¤āĻ āĻŦā§āĻ¸ āĻŦāĻžā§āĻžāĻ° āĻ¸āĻžāĻĨā§ āĻ¸āĻžāĻĨā§ āĻŽāĻžāĻ¨ā§āĻˇā§āĻ° āĻ°ā§āĻ āĻŦā§āĻ¯āĻ§āĻŋ āĻ āĻŦā§ā§ā§ āĻ¯āĻžā§āĨ¤ āĻāĻžāĻ°āĻŖ āĻ āĻ¸āĻŽā§ āĻŽāĻžāĻ¨ā§āĻˇā§āĻ° āĻ°ā§āĻ āĻĒā§āĻ°āĻ¤āĻŋāĻ°ā§āĻ§ āĻā§āĻˇāĻŽāĻ¤āĻž āĻ āĻ āĻ¨ā§āĻ āĻāĻŽā§ āĻ¯āĻžā§āĨ¤ āĻ¯āĻžāĻ° āĻāĻžāĻ°āĻŖā§ āĻ¸āĻŦ āĻ¸āĻŽā§ āĻāĻˇāĻ§ āĻā§ā§ā§āĻ āĻŦā§āĻāĻā§ āĻĨāĻžāĻāĻ¤ā§ āĻšā§āĨ¤ āĻŽāĻžā§ā§āĻ° āĻāĻˇāĻ§ āĻāĻžāĻā§āĻžā§ āĻāĻŋāĻˇāĻ¨ āĻ°āĻāĻŽ āĻ āĻ¨āĻŋā§āĻŽ āĻ°ā§ā§āĻā§, āĻ¯āĻžāĻ° āĻāĻžāĻ°āĻŖā§ āĻ¸ā§ āĻāĻŋāĻā§āĻĻāĻŋāĻ¨ āĻĒāĻ°ā§ āĻĒāĻ°ā§āĻ āĻ āĻ¸ā§āĻ¸ā§āĻĨ āĻšā§ā§ āĻĒā§ā§āĨ¤ ||| |---|---| |**āĻāĻŋāĻ¤ā§āĻ°āĻ āĻĄāĻžāĻā§āĻ¤āĻžāĻ°ā§ āĻĢāĻžāĻāĻ˛ āĻāĻŦāĻ āĻĒā§āĻ°ā§āĻ¸āĻā§āĻ°āĻŋāĻĒāĻļāĻ¨āĨ¤**| āĻāĻŽāĻžāĻ° āĻŽāĻ¨ā§ āĻšā§ āĻāĻ āĻŦā§āĻ¸ā§ āĻāĻ¸ā§ āĻļā§āĻ§ā§ āĻĄāĻžāĻā§āĻ¤āĻžāĻ° āĻĻā§āĻāĻžāĻ˛ā§āĻ āĻšāĻŦā§ āĻ¨āĻž āĻĄāĻžāĻā§āĻ¤āĻžāĻ°ā§āĻ° āĻ¨āĻŋā§āĻŽ āĻāĻŦāĻ āĻĒāĻ°āĻžāĻŽāĻ°ā§āĻļ āĻ āĻ¨ā§āĻ¯āĻžā§ā§ āĻ āĻāĻ˛āĻžāĻāĻž āĻ āĻ¤ā§āĻ¯āĻžāĻŦāĻļā§āĻ¯āĻāĨ¤</div> āĻŦāĻ¨ā§āĻ§ā§āĻ°āĻž, āĻāĻŽāĻžāĻ° āĻĒā§āĻ¸ā§āĻāĻāĻŋ āĻāĻˇā§āĻ āĻāĻ°ā§ āĻāĻĒāĻ¨āĻžāĻĻā§āĻ° āĻŽā§āĻ˛ā§āĻ¯āĻŦāĻžāĻ¨ āĻ¸āĻŽāĻ¯āĻŧ āĻ¨āĻˇā§āĻ āĻāĻ°ā§ āĻāĻŋāĻāĻŋāĻ āĻāĻ°āĻžāĻ° āĻāĻ¨ā§āĻ¯ āĻ¸āĻŦāĻžāĻāĻā§ āĻāĻ¨ā§āĻ¤āĻ°āĻŋāĻ āĻ§āĻ¨ā§āĻ¯āĻŦāĻžāĻĻāĨ¤ āĻ¸āĻŦāĻžāĻ āĻāĻŽāĻžāĻ° āĻŽāĻžāĻ¯āĻŧā§āĻ° āĻāĻ¨ā§āĻ¯ āĻĻā§āĻ¯āĻŧāĻž āĻāĻ°āĻŦā§āĻ¨āĨ¤ āĻāĻ˛ā§āĻ˛āĻžāĻš āĻ¯ā§āĻ¨ āĻ¤āĻžāĻā§ āĻ¸āĻŦ āĻ¸āĻŽāĻ¯āĻŧ āĻ¸ā§āĻ¸ā§āĻĨ āĻ°āĻžāĻā§āĻ¨āĨ¤ āĻāĻžāĻ˛ā§ āĻĨāĻžāĻāĻŦā§āĻ¨ āĻ¸āĻŦāĻžāĨ¤ āĻāĻ˛ā§āĻ˛āĻžāĻš āĻšāĻžāĻĢā§āĻāĨ¤  <div class="pull-left">https://cdn.steemitimages.com/DQmXKPyydoaz3nwFV899PaLrnBMD2QgvjXn4gRzXZ5f4LH3/222.jpg</div> <div class=text-justify>āĻāĻŽāĻŋ āĻāĻāĻŋāĻā§āĻ˛ āĻŽāĻŋā§āĻžāĻ, āĻāĻŽāĻžāĻ° āĻā§āĻ°āĻžāĻŽā§āĻ° āĻŦāĻžā§āĻŋ āĻŽāĻžāĻĻāĻžāĻ°ā§āĻĒā§āĻ°āĨ¤ āĻāĻŽāĻŋ āĻāĻā§āĻ¨āĻ¨āĻžāĻĨ āĻŦāĻŋāĻļā§āĻŦāĻŦāĻŋāĻĻā§āĻ¯āĻžāĻ˛ā§ āĻĨā§āĻā§ āĻŦāĻžāĻāĻ˛āĻžā§ āĻ āĻ¨āĻžāĻ°ā§āĻ¸-āĻŽāĻžāĻ¸ā§āĻāĻžāĻ°ā§āĻ¸ āĻļā§āĻˇ āĻāĻ°ā§ āĻŦāĻ°ā§āĻ¤āĻŽāĻžāĻ¨ā§ āĻāĻāĻāĻŋ āĻĒā§āĻ°āĻžāĻāĻā§āĻ āĻā§āĻŽā§āĻĒāĻžāĻ¨ā§āĻ¤ā§ āĻŽā§āĻ¯āĻžāĻ¨ā§āĻāĻžāĻ° āĻĒāĻĻā§ āĻāĻ°ā§āĻŽāĻ°āĻ¤ āĻāĻāĻŋāĨ¤ āĻ˛āĻŋāĻāĻ¤ā§ āĻāĻŽāĻžāĻ° āĻ āĻ¨ā§āĻ āĻŦā§āĻļāĻŋ āĻāĻžāĻ˛ā§ āĻ˛āĻžāĻā§āĨ¤ āĻāĻŽāĻŋ āĻā§āĻ āĻŦā§āĻ˛āĻž āĻĨā§āĻā§āĻ āĻāĻŽ-āĻŦā§āĻļāĻŋ āĻ˛ā§āĻāĻž-āĻ˛ā§āĻāĻŋ āĻāĻ°āĻ¤āĻžāĻŽāĨ¤ āĻ˛ā§āĻāĻž-āĻ˛ā§āĻāĻŋāĻ° āĻĒāĻžāĻļāĻž-āĻĒāĻžāĻļāĻŋ āĻāĻŽāĻŋ āĻā§āĻ°āĻ¤ā§ āĻāĻŦāĻ āĻā§āĻ˛āĻž-āĻ§ā§āĻ˛āĻž āĻāĻ°āĻ¤ā§ āĻ āĻ¨ā§āĻ āĻĒāĻāĻ¨ā§āĻĻ āĻāĻ°āĻŋāĨ¤ āĻ¸āĻŽā§ āĻĒā§āĻ˛ā§āĻ āĻĒāĻ°āĻŋāĻŦāĻžāĻ°ā§āĻ° āĻ¸āĻĻāĻ¸ā§āĻ¯āĻĻā§āĻ° āĻ¨āĻŋā§ā§ āĻā§āĻ°āĻ¤ā§ āĻŦā§āĻ° āĻšāĻāĨ¤ āĻ āĻ¤āĻŋāĻ°āĻŋāĻā§āĻ¤ āĻāĻĨāĻž āĻŦāĻ˛āĻž āĻāĻŦāĻ āĻŽāĻŋāĻĨā§āĻ¯āĻž āĻāĻĨāĻž āĻŦāĻ˛āĻž āĻāĻŽāĻŋ āĻ¸āĻŦāĻā§ā§ā§ āĻŦā§āĻļāĻŋ āĻ āĻĒāĻāĻ¨ā§āĻĻ āĻāĻ°āĻŋāĨ¤</i></div> āĻĒā§āĻ¸ā§āĻ āĻ¸āĻŽā§āĻĒāĻ°ā§āĻāĻŋāĻ¤ āĻ¯āĻž āĻ¯āĻž- |āĻĄāĻŋāĻāĻžāĻāĻ¸ā§āĻ° āĻ¨āĻžāĻŽ |āĻŽāĻĄā§āĻ˛ |āĻā§āĻ¯āĻžāĻŽā§āĻ°āĻž| |---|---|---| |TECNO|Pouvoir 4|13M QUAD| |āĻā§āĻ¯āĻžāĻŽā§āĻ°āĻžā§| āĻ¸ā§āĻĨāĻžāĻ¨ | |---|---| |@azizulmiah| āĻŽāĻŋāĻ°āĻĒā§āĻ°|    
Global Market Insights recently added a detailed market research study focused on the Global Influenza Diagnostic Tests Market across the global, regional and country level. The report provides 360ð analysis of Influenza Diagnostic Tests Market from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Influenza Diagnostic Tests market and estimates the future trend of Global Influenza Diagnostic Tests industry on the basis of this detailed study.
Browse key industry insights spread across 120 pages with 233 market data tables & 14 figures & charts from the report, âInfluenza Diagnostic Tests Market Analysis By Test Type (Traditional Diagnostic Test {Rapid Influenza Diagnostic Test (RIDT), Direct Fluorescent Antibody Test (DFAT), Viral Culture, Serological Assay}, Molecular Diagnostic Assay {RT-PCR, Loop-mediated Isothermal Amplification-based Assay (LAMP), Nucleic Acid Sequence-based Amplification Test (NASBAT), Simple Amplification-based Assay (SAMBA)}), End-use (Hospitals, Diagnostics Centers, Research Laboratories), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 â 2028â in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/influenza-diagnostic-tests-market
In addition, the World Health Organization claims that the annual influenza epidemics during winter and autumn affect nearly 5 to 15% of the population in the Northern hemisphere. Increase in such cases would foster the need for the development of diagnostic tests for influenza.
The overall influenza diagnostic tests market has been classified on the basis of end-use, test type, and regional landscape.
Considering the test type, the market is segmented into traditional diagnostic test and molecular diagnostic assay.
Out of these two, the industry would observe substantial growth from the molecular diagnostic assay segment, which was valued at more than $668 million. Going further, industry analysts expect the segment to expand at a CAGR of 8.5% through the analysis timeline. This can be credited to the test's capability to deliver effective and accurate testing, which is in line with its ability to offer improved efficacy, resulting in enhanced outcomes.
From the end-use standpoint, the hospitals segment has been observing a stellar growth in the global influenza diagnostic tests market. The sector was valued at $565 million in 2021, with projections expecting it to grow at an unprecedented pace in the coming years. The growth would come from positive factors such as high success rate, availability of board-certified professional doctors, and faster and high effective work, amongst others.
Geographically, Latin America influenza diagnostic tests market has been gaining significant momentum over the recent years. In 2021, the regional market share was over $173 million, and is now predicted to grow at a CAGR of 8.3% over the stipulated time frame.
The regional industry development is supported by the growing pervasiveness of influenza and surging cognizance regarding the flu infection cases in the economies like Mexico, and Brazil, among others. A recent study displayed that seasonal influenza was associated with nearly 36,500 respiratory deaths and about 400,000 hospitalizations in Latin America and the Caribbean.
Abbott, Thermo Fischer Scientific Inc., Quidel Corporation, F. Hoffmann-La Roche Ltd., Meridian Bioscience Inc., DiaSorin SpA, and Dickinson and Company are some of the prominent companies operating in the global influenza diagnostic tests market.
Partial Table of Contents (ToC) of the report:
Chapter 5 Influenza Diagnostic Tests Market, By End-use
5.1 Key segment trends
5.2 Hospitals
5.2.1 Market size, by region, 2016 â 2027 (USD Million)
5.3 Diagnostics centers
5.3.1 Market size, by region, 2016 â 2027 (USD Million)
5.4 Research laboratories
5.4.1 Market size, by region, 2017 - 2028 (USD Million)
5.5 Others
5.5.1 Market size, by region, 2017 - 2028 (USD Million)
Chapter 6 Influenza Diagnostic Tests Market, By Region
6.1 Key regional trends
6.2 North America
6.2.1 Market size, by country, 2017 - 2028 (USD Million)
6.2.2 Market size, by test type, 2017 - 2028 (USD Million)
6.2.2.1 Market size, by traditional diagnostic test, 2017 - 2028 (USD Million)
6.2.2.2 Market size, by molecular diagnostic assay, 2017 - 2028 (USD Million)
6.2.3 Market size, by end-use, 2016 â 2027 (USD Million)
6.2.4 U.S.
6.2.4.1 Market size, by test type, 2017 - 2028 (USD Million)
6.2.4.1.1 Market size, by traditional diagnostic test, 2017 - 2028 (USD Million)
6.2.4.1.2 Market size, by molecular diagnostic assay, 2017 - 2028 (USD Million)
6.2.4.2 Market size, by end-use, 2016 â 2027 (USD Million)
Browse complete table of content of this report @ https://www.gminsights.com/toc/detail/influenza-diagnostic-tests-market
About Global Market Insights
Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Contact Us
Arun Hegde
Corporate Sales, USA
Global Market Insights Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.comGlobal Market Insights add New Global Rapid Influenza Diagnostic Tests (RIDT) Market report provides in-depth information about market overview, top vendors, Key market highlights, product types, market drivers, challenges, trends, Rapid Influenza Diagnostic Tests (RIDT) industry landscape, size and forecast, five forces analysis, Key leading countries/Region. The rapid influenza diagnostic tests (RIDT) market is expected to grow significantly by 2030 owing to increasing prevalence of influenza. In addition, surging necessity for early diagnosis, along with rising popularity of rapid testing, is set to further boost market growth through the forecast period. Browse key industry insights spread across 80 pages with 69 market data tables & 12 figures & charts from the report, âRapid Influenza Diagnostic Tests Market Size By End-use (Hospitals, Diagnostics Centers, Research Laboratories), Industry Analysis Report, Regional, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 â 2030â in detail along with the table of contents: https://www.gminsights.com/industry-analysis/rapid-influenza-diagnostic-tests-ridt-market Notably, lack of skilled professionals and stringent lockdown regulations imposed during the COVID-19 outbreak posed a threat to market growth However, with the burgeoning number of cases and high risk of exposure to COVID-19 in hospital settings, at-home testing gained massive popularity. Thus, rising consumer interest in at-home testing kits, coupled with soaring demand for telemedicine for influenza infection diagnosis, has positively impacted the product landscape of the rapid influenza diagnostic tests (RIDT) market. Furthermore, major players in the industry have been focusing on research and development activities to introduce technologically advanced rapid influenza tests. In addition, strategic partnerships and acquisitions have also aided in business expansion. For instance, in October 2020, Quidel Corporation, a leading manufacturer of diagnostic healthcare products, received EUA (Emergency Use Authorization) from the U.S. FDA (Food and Drug Administration) for marketing its Sofia 2 Flu + SARS Antigen FIA, a rapid point-of-care test used in conjunction with Sofia 2 Fluorescent Immunoassay Analyzer to differentiate nucleocapsid protein antigen from SARS-CoV-2 and influenza A and B via direct nasal (NS) and nasopharyngeal (NP) swab samples in potential COVID-19 patients. To cite another instance, in March 2021, Abbott, a multinational medical and healthcare devices company, introduced its Alinity m Resp-4-Plex assay that detects COVID-19, influenza A, influenza B, and RSV using only one swab. The innovation, which has received U.S. FDA Emergency Use Authorization, aims to reduce discomfort, and give an efficient four-in-one assay for quick diagnosis. In another instance, in January 2021, Thermo Fisher Scientific, a prominent supplier in the rapid influenza diagnostic tests (RIDT) market, announced its plans to takeover molecular diagnostic expert Mesa Biotech. Mesa provides gold-standard nucleic acid PCR (polymerase chain reaction) amplification to point-of-care diagnostics for COVID-19, RSV, Influenza A and B, and Strep A. Partial Table of Contents (ToC) of the report: Chapter 4 Rapid Influenza Diagnostic Tests Market, By End-use 4.1 Key segment trends 4.2 Hospitals 4.2.1 Market size, by region, 2017 - 2030 (USD Million) 4.3 Diagnostics centers, 4.3.1 Market size, by region, 2017 - 2030 (USD Million) 4.4 Research laboratories 4.4.1 Market size, by region, 2017 - 2030 (USD Million) 4.5 Others 4.5.1 Market size, by region, 2017 - 2030 (USD Million) Chapter 5 Rapid Influenza Diagnostic Tests Market, By Region 5.1 Key regional trends 5.2 North America 5.2.1 Market size, by country, 2017 - 2030 (USD Million) 5.2.2 Market size, by end-use, 2017 - 2030 (USD Million) 5.2.3 U.S. 5.2.3.1 Market size, by end-use, 2017 - 2030 (USD Million) 5.2.4 Canada 5.2.4.1 Market size, by end-use, 2017 - 2030 (USD Million) 5.3 Europe 5.3.1 Market size, by country, 2017 - 2030 (USD Million) 5.3.2 Market size, by end-use, 2017 - 2030 (USD Million) 5.3.3 Germany 5.3.3.1 Market size, by end-use, 2017 - 2030 (USD Million) 5.3.4 UK 5.3.4.1 Market size, by end-use, 2017 - 2030 (USD Million) 5.3.5 France 5.3.5.1 Market size, by end-use, 2017 - 2030 (USD Million) 5.3.6 Italy 5.3.6.1 Market size, by end-use, 2017 - 2030 (USD Million) 5.3.7 Spain 5.3.7.1 Market size, by end-use, 2017 - 2030 (USD Million) 5.4 Asia Pacific 5.4.1 Market size, by country, 2017 - 2030 (USD Million) 5.4.2 Market size, by end-use, 2017 - 2030 (USD Million) 5.4.3 China 5.4.3.1 Market size, by end-use, 2017 - 2030 (USD Million) 5.4.4 Japan 5.4.4.1 Market size, by end-use, 2017 - 2030 (USD Million) 5.4.5 India 5.4.5.1 Market size, by end-use, 2017 - 2030 (USD Million) Browse complete table of content of this report @ https://www.gminsights.com/toc/detail/rapid-influenza-diagnostic-tests-ridt-market About Global Market Insights Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology. Contact Us Arun Hegde Corporate Sales, USA Global Market Insights Inc. Phone: 1-302-846-7766 Toll Free: 1-888-689-0688 Email: sales@gminsights.com
<p>The Factors such as the increasing geriatric population and rising incidence of lifestyle & cardiovascular diseases are expected to propel the growth of the market.</p> <p>According to the new market research report <a href="https://www.marketsandmarkets.com/Market-Reports/Diagnostic-ECG-global-Market-173.html">Diagnostic Electrocardiograph Market</a> is expected to reach $10.3 billion by 2024, at a CAGR of 6.4% during the forecast period.</p> <p>The 3-lead segment is expected to grow at the highest CAGR during the forecast period. By lead type, the diagnostic ECG market is divided into 12-lead, 5-lead, 3-lead, 6-lead, single-lead, and other lead types (15- and 18-lead). This positive growth is primarily due to the fact that these leads are used conjointly with various other cardiac diagnostic tests and during medical procedures.</p> <p>The Diagnostic Electrocardiograph (ECG) Market is dominated by players such as GE Healthcare (US), Nihon Kohden (Japan), Philips Healthcare (Netherlands), Hill-Rom Holdings (US), and Ambu (Denmark).</p> <p>Download PDF Brochure: <a href="https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173">https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173</a></p>
 Why Should You Own a Car Diagnostic Tool? Our vehicles are not infallible, and when something inevitably goes wrong, you may struggle to figure out the problem without a car diagnostic tool. Well, you could just call roadside assistance or your trusted mechanic and wait around helplessly for however long it takes. Read more - <a href="https://carbuzz.com/car-advice/benefits-of-buying-a-car-diagnostic-tool">Benefits Of Buying A Car Diagnostic Tool</a>
A recent study conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the global artificial intelligence diagnostic market was worth USD 416.1 million in the year 2020. The market is estimated to grow at a CAGR of 39.2%, earning revenue of around USD 4,164.0 million by the end of 2027. In healthcare, artificial intelligence (AI) is employed to optimize human perception and to extract insights from complex medical and diagnostic imaging data. It is mostly used in healthcare to investigate the association between treatment methods and patient outcomes. Considering the advantages offered by AI-enabled healthcare technology, AI programs are widely deployed in medical practices such as diagnostic procedures, drug growth, personalized medicines, and patient testing care, which in turn contributes to the growth of the global artificial intelligence diagnostic market. Increasing strategic partnerships among various AI solution providers and health facilities boosting the market growth Growing strategic partnerships and collaborations among AI solution providers and healthcare facilities is yet another factor influencing the market growth. For example, in August 2019, Boston-based Partners HealthCare partnered with FUJIFILM SonoSite, Inc. to apply artificial intelligence to transportable ultrasound technology used for point-of-care diagnostics. Partners HealthCare's clinical expertise, databases, and IT infrastructure will be combined with FUJIFILM's portable ultrasound technology to develop AI-powered devices as part of this collaboration. These devices, which are utilized in emergency medical procedures, reduce the period between trauma and diagnosis, allowing for faster treatments and enhancing patient recovery. The Imaging & Diagnostic Application Estimated to Boost The Global Artificial Intelligence Diagnostic Market In The Forecast Period Based on application, the global artificial intelligence diagnostic market is segmented into imaging & diagnostics, drug discovery, lifestyle management & monitoring, emergency room & hospital management, insights & risk analytics, wearables, virtual assistants, and others. During the forecast period, the medical imaging & diagnostics segment of the AI healthcare market is predicted to hold the highest CAGR. Factors such as the existence of a large volume of imaging data, the returns offered by AI systems to radiologists in analysis and cure management, and the influx of a large number of startups contribute to the substantial development of medical imaging and diagnostics in this section. Sample Copy :https://www.blueweaveconsulting.com/global-artificial-intelligence-diagnostic-market-bwc20108/report-sample The Hospital Segment is Driving the Global Artificial Intelligence Diagnostic Market Based on end-users, the global artificial intelligence diagnostic market is categorized into hospitals, pharmaceutical organizations, diagnostic centers, and clinics. The hospital segment accounted for the largest market share and is projected to grow at a high CAGR in the forecast period as well. Growing demand for modified care, the need to reduce hospital readmissions, and the suitability and answers offered by AI products are the key elements driving the development of the patient's section in the AI in the healthcare market. Global Artificial Intelligence Diagnostic Market - Regional Insights Geographically, the global artificial intelligence diagnostic market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle-East & Africa. North America holds the largest market share owing to the high adoption of advanced technology such as AI in healthcare. The high concentration of major AI market players in this region also accelerates the research and development activities, which further contributes to the market growth in this region. The Asia Pacific is predicted to be the most profitable market growing at a remarkable growth rate during the forecast period. Cost-efficiency is the major factor predicted to drive the growth of the market for AI in diagnostics in the Asia Pacific during the prediction period. Furthermore, the rising demand for e-diagnostic services in the healthcare industry as a result of increased government spending on healthcare propels the Asia Pacific market forward. Impact of COVID-19 on Global Artificial Intelligence Diagnostic Market The global artificial intelligence diagnostic market has flourished significantly in the post-COVID-19 era. Following the COVID-19 outbreak, the use of AI diagnostic methods for identifying viral presence in the human body increased substantially. AI technologies are increasingly being utilized to scan hospital visitors for the presence of COVID-19, ensuring the safety of both healthcare professionals and medical staff. Furthermore, these cutting-edge technologies are being used to monitor the vitals of COVID-19 patients and provide them with the necessary care. Competitive Landscape The leading market players in the global artificial intelligence diagnostic market are IBM Corporation, Google, Inc., NVIDIA Corporation, Microsoft Corporation, ICarbonX, Next IT Corp., CloudMex Inc., Carescore, Atomwise Inc., Zephyr Health Inc., Deep Genomics Inc., Medtronic PLC., Koninklijke Philips N.V., Oncora Medical, Inc., Zebra Medical Vision, Riverain Technologies, Siemens Healthcare GmbH, Neural Analytics, Imagen Technologies, and other prominent players. The adoption of competitive strategies like partnerships, mergers, collaboration, joint ventures, etc. is highly prevalent in the market. Furthermore, in order to expand their product portfolio and market reach, the market players have been continuously focused on and investing in technological advancements and research & development to improve their solutions. About Us: Blueweave Consulting offers a one-stop solution for your market intelligence needs for any service or product. You get well-researched comprehensive reports based on qualitative and quantitative data to put your business plan into action. Your well-informed and timely decisions using our reports avert situations of excessive risks and help you grow your business with optimum risk-return trade-off.
The Global Diagnostic Electrocardiograph Market, Trends, Analysis and forecasts 2020-30 gives a brief idea on the key developments, business strategies, research & latest innovations and key events in the industry and market composition analysis. The global diagnostics electrocardiograph market size was estimated to be US$ 7.6 billion in 2019 and is expected to reach US$ 14.9 billion by 2030 at a CAGR of 6.3%. Diagnostic Electrocardiograph is a device that is used in diagnosis of several heart issues. It is a non-invasive and painless way of diagnosis. It is used to determine and detect the abnormality of heart rhythm. Electrocardiograph is used in the diagnosis of several cardiac indications which includes cardiac stress testing, fainting, cardiac murmur, and myocardial infarction. <p>Read More@<a title="https://www.globenewswire.com/en/news-release/2021/01/06/2154448/0/en/Diagnostic-Electrocardiograph-Market-Sales-Is-Expected-To-Reach-US-14-9-billion-by-2030-Globally.html" href="https://www.globenewswire.com/en/news-release/2021/01/06/2154448/0/en/Diagnostic-Electrocardiograph-Market-Sales-Is-Expected-To-Reach-US-14-9-billion-by-2030-Globally.html">https://www.globenewswire.com/en/news-release/2021/01/06/2154448/0/en/Diagnostic-Electrocardiograph-Market-Sales-Is-Expected-To-Reach-US-14-9-billion-by-2030-Globally.html</a></p> %20Market1.jpg)
<p>Global <a href="https://www.millioninsights.com/industry-reports/cervical-cancer-diagnostic-market?utm_source=steemit&utm_medium=Referral&utm_campaign=JyotiG21May21" target="_blank"><em><strong>Cervical Cancer Diagnostic Market</strong></em></a><em> </em>size is anticipated to reach USD 12 billion by 2024. Cervical cancer is caused due to uncontrolled cell division of cancerous or abnormal cell growth in the cervix region. The factors that propel the growth of the cervical cancer diagnostics market include increase in aging female population, rise in the awareness programs for cervical cancer screening, high occurrence rate, and rapid adoption of technology. Moreover, increasing consciousness among the population regarding prevention, care, and treatment of cervical cancer, and availability of advanced and variety of treatment are likely to offer impetus to the market.</p> <p>On the other hand, there are factors that may hamper the growth of the market including lack of awareness related to cervical cancer protection, and changes in regulatory guidelines for cervical cancer screening. Cervical cancer diagnostics industry is anticipated to grow at a significant CAGR of 5.9% in the upcoming period as the scope, product types, and its applications are increasing across the globe.</p> <p>Cervical cancer diagnostic market could be explored by type, age group, therapy, end user, and geography. The market could be explored by test type as HPV Testing, Pap Testing, Cytology Testing, Colposcopy, Cystoscopy, and Cervical Biopsies. The “Pap Testing” segment led the cervical cancer diagnostic industry in 2015 and is anticipated to maintain its dominance by 2024. The key factors that may be attributed to the growth of market include high efficiency of the tests in initial diagnosis and increasing consciousness about the impact of the initial diagnosis.</p> <p>Cervical cancer diagnostics market could be explored by age group as below 35 years and 35 years & above. The market could be explored by therapies as Radiation therapy, Surgery, Targeted therapy, and Chemotherapy. Cervical cancer diagnostic industry could be explored by the end user as Laboratories, Hospitals, and Others (Clinics and Independent physicians).</p> <p><em><strong>Request a Free Sample Copy of Cervical Cancer Diagnostic Market Report @ <a href="https://www.millioninsights.com/industry-reports/cervical-cancer-diagnostic-market/request-sample?utm_source=steemit&utm_medium=Referral&utm_campaign=JyotiG21May21" target="_blank">https://www.millioninsights.com/industry-reports/cervical-cancer-diagnostic-market/request-sample</a></strong></em></p> <p>North America accounted for the major market share of the cervical cancer diagnostic in 2016 and will continue to lead in the forecast period. The factors that could be attributed to the growth include high occurrence rate of cervical cancer, growing acceptance of cervical cancer screening procedures, huge investments by pharmaceutical and Biotechnological Companies in research centers, high spending on latest technology, and easy accessibility to healthcare facilities. North America is likely to be followed by the European region in the forecast period.</p> <p>Some of the key players that fuel the growth of the cervical cancer diagnostics industry comprise Cooper Surgical, Inc.; Abbott Laboratories; Dickinson and Company (BD); Becton, Quest Diagnostics; Hologic, Inc.; QIAGEN; Siemens; Guided Therapeutics; Arbor Vita; OncoHealth Corp.; Beckman Coulter, Inc. and Zilico Ltd. The leading companies are taking up partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.</p> <p><strong>Market Segment:</strong></p> <p><strong>Test type outlook (Market revenue in USD Billion, 2013 - 2024)</strong><br /> • Pap Testing<br /> • HPV Testing<br /> • Colposcopy<br /> • Cervical Biopsies<br /> • Cystoscopy</p> <p><strong>Browse the Full Global Cervical Cancer Diagnostic Market - Global Scenario, Industry Outlook, Analysis, Size, Trends and Forecast, 2013 To 2024 Report at - <a href="https://www.millioninsights.com/industry-reports/cervical-cancer-diagnostic-market?utm_source=steemit&utm_medium=Referral&utm_campaign=JyotiG21May21" target="_blank">https://www.millioninsights.com/industry-reports/cervical-cancer-diagnostic-market</a></strong></p> <p><strong>Regional outlook (Market revenue in USD Billion, 2013 - 2024)</strong><br /> • North America<br /> • U.S.<br /> • Canada<br /> • Europe<br /> • UK<br /> • Germany<br /> • Asia Pacific<br /> • Japan<br /> • China<br /> • Latin America<br /> • Brazil<br /> • Mexico<br /> • Middle East and Africa<br /> • South Africa</p>
# Scanwell Health UTI Test Test and treat UTIs from your smartphone --- ## Screenshots <center><img alt="healthyio_1-7.mp4" src="https://s3-us-west-2.amazonaws.com/steemhunt/production/steemhunt/2021-05-04/52944e49-healthyio_1-7-thumb.jpg"/></center> | <center><img alt="8cdd01d7-1a0c-41c2-a677-e88921ed301e.jpeg" src="https://s3-us-west-2.amazonaws.com/steemhunt/production/steemhunt/2021-05-04/8194c0b0-8cdd01d7-1a0c-41c2-a677-e88921ed301e.jpeg"/><br><a href="https://s3-us-west-2.amazonaws.com/steemhunt/production/steemhunt/2021-05-04/8194c0b0-8cdd01d7-1a0c-41c2-a677-e88921ed301e.jpeg">View Image</a></center> | <center><img alt="63107779-ce0c-4a56-a77d-a4fb5866be9b.jpeg" src="https://s3-us-west-2.amazonaws.com/steemhunt/production/steemhunt/2021-05-04/5e0a668c-63107779-ce0c-4a56-a77d-a4fb5866be9b.jpeg"/><br><a href="https://s3-us-west-2.amazonaws.com/steemhunt/production/steemhunt/2021-05-04/5e0a668c-63107779-ce0c-4a56-a77d-a4fb5866be9b.jpeg">View Image</a></center> | <center><img alt="81495a3d-8721-43ca-99a1-aaca1ba5becc.jpeg" src="https://s3-us-west-2.amazonaws.com/steemhunt/production/steemhunt/2021-05-04/430c57ba-81495a3d-8721-43ca-99a1-aaca1ba5becc.jpeg"/><br><a href="https://s3-us-west-2.amazonaws.com/steemhunt/production/steemhunt/2021-05-04/430c57ba-81495a3d-8721-43ca-99a1-aaca1ba5becc.jpeg">View Image</a></center> | <center><img alt="fe579f04-163b-4743-905f-2b26d94c72f0.jpeg" src="https://s3-us-west-2.amazonaws.com/steemhunt/production/steemhunt/2021-05-04/00a499d1-fe579f04-163b-4743-905f-2b26d94c72f0.jpeg"/><br><a href="https://s3-us-west-2.amazonaws.com/steemhunt/production/steemhunt/2021-05-04/00a499d1-fe579f04-163b-4743-905f-2b26d94c72f0.jpeg">View Image</a></center> | <center><img alt="79d74961-8f59-4bcb-ac0f-4f7103b86cb0.jpeg" src="https://s3-us-west-2.amazonaws.com/steemhunt/production/steemhunt/2021-05-04/f295fe2f-79d74961-8f59-4bcb-ac0f-4f7103b86cb0.jpeg"/><br><a href="https://s3-us-west-2.amazonaws.com/steemhunt/production/steemhunt/2021-05-04/f295fe2f-79d74961-8f59-4bcb-ac0f-4f7103b86cb0.jpeg">View Image</a></center> | | - | - | - | - | - | | --- ## Hunter's comment Scanwell is a modern diagnostics company. We've created the only at-home UTI test with same-day treatment options. Get test results in 2 minutes and immediately connect to treatment, all from your smartphone. https://youtu.be/eXxucYR3QyA --- ## Link https://www.scanwellhealth.com/tests/urinary-tract-infection-test --- <center><br/><br/> This is posted on Steemhunt - A place where you can dig products and earn STEEM. [View on Steemhunt.com](https://steemhunt.com/@arianna22/scanwell-health-uti-test-test-and-treat-utis-from-your-smartphone) </center>
The Global Diagnostic Electrocardiograph Market, Trends, Analysis and forecasts 2020-30 gives a brief idea on the key developments, business strategies, research & latest innovations and key events in the industry and market composition analysis. The global diagnostics electrocardiograph market size was estimated to be US$ 7.6 billion in 2019 and is expected to reach US$ 14.9 billion by 2030 at a CAGR of 6.3%. Diagnostic Electrocardiograph is a device that is used in diagnosis of several heart issues. It is a non-invasive and painless way of diagnosis. It is used to determine and detect the abnormality of heart rhythm. Electrocardiograph is used in the diagnosis of several cardiac indications which includes cardiac stress testing, fainting, cardiac murmur, and myocardial infarction. <p>Read More@<a title="https://www.globenewswire.com/news-release/2021/01/06/2154448/0/en/Diagnostic-Electrocardiograph-Market-Sales-Is-Expected-To-Reach-US-14-9-billion-by-2030-Globally.html" href="https://www.globenewswire.com/news-release/2021/01/06/2154448/0/en/Diagnostic-Electrocardiograph-Market-Sales-Is-Expected-To-Reach-US-14-9-billion-by-2030-Globally.html">https://www.globenewswire.com/news-release/2021/01/06/2154448/0/en/Diagnostic-Electrocardiograph-Market-Sales-Is-Expected-To-Reach-US-14-9-billion-by-2030-Globally.html</a></p> %20Market1.jpg)
Market Highlights: Diagnostic imaging helps to understand the functioning of body parts and create visual representation of interior of the body and provides support in detection of medical disorder. The continues increase in geriatric population, increasing prevalence of chronic diseases, and technological advancements are the major factors driving the growth of the global diagnostic imaging market. Additionally, increasing investment in R&D and aggressive strategies adopted by the major players, such as new product launches along with merger and acquisitions, are contributing to the growth of the market. For instance, in March 2017, General Electric Company announced the acquisition of Monica healthcare for undisclosed amount, with this transaction the company will gain control over 1000 sites of Monica healthcare across Europe, Asia and North America. The global diagnostic imaging market size is expected to grow during the forecast period (2018â2023) at a CAGR ~6.2%. The high costs associated with diagnostic imaging devices, unfavorable reimbursement policies and scarcity of technicians are likely to hinder market growth during the forecast period. Segmentation: The global diagnostic imaging market has been segmented on the basis of product, source, and application. Based on product type, the market has been divided into x-ray equipment, ultrasound imaging systems, nuclear imaging systems, magnetic resonance imaging (MRI), computed tomography (CT) scanners, and other products The market, by application, has been segmented into gynecology, oncology, orthopedics, cardiology, gastroenterology, neurology, and other applications The end-user segment has been further divided into hospitals and clinics, diagnostic centers, research institutes, and others. Key Players: Some of the key players in the global diagnostic imaging market are Siemens Healthcare Private Limited, Koninklijke Philips N.V.,CANON MEDICAL SYSTEMS CORPORATION, Shimadzu Corporation, Carestream Health,Esoate SpA, GE Healthcare, Toshiba Medical Systems Corporation,FUJIFILM Holdings Corporation, Hitachi Medical Systems, and Hologic Inc. https://www.marketresearchfuture.com/reports/diagnostic-imaging-market-6765
Janta X-Ray Clinic is having 42+ years of excellence in diagnostic service. This is a unique concept based path lab along with the latest high-tech machines. This is a very unique world-class <a href="https://www.jantaxray.in/ultrasound.html">ultrasound scan centre near me in Delhi NCR</a> that serves accurate reports and gives better patient care. Visit our official website for more details and services. 
The Diagnostic Electrocardiograph (ECG) Market was worth US$ 7.6 Billion in 2019 and is expected to grow at a CAGR of 6.3% through 2030. Diagnostic electrocardiograph is a is a clinical gadget that analyze the cardiac issues identified with the electrical movement of the heart. Electrocardiograph is performed for various cardiac indications including fainting, myocardial infraction, cardiac stress testing, and cardiac murmur. Rising prevalence of cardiovascular diseases and lifestyle related diseases like peripheral artery diseases, ischemic heart disease (IHD), stroke, and hypertensive heart disease which it will eventually lead to spending towards health or testing resulting into market growth. Moreover, supportive reimbursement policies, enhancing healthcare infrastructure, and increasing aging population are some of the other factors which are likely to poise a positive impact on the market growth. With rising technological advancements, introduction of innovative and advanced products and services such as development of remote monitoring ECG devices are expected to create ample opportunities for the growth of global diagnostic electrocardiograph (ECG) market. The growth of diagnostic electrocardiograph (ECG) market in developed nations such as U.S., Canada is saturated, however emerging economies such as China, India, and Japan are witnessing continuous growth and are expected to grow rapidly during the forecast period. The growth of market in developing nations can be accredited to companyâs focus on exploring untapped market, significant healthcare expenditure, and supportive government policies. The global market is highly competitive hence the companies are engaged in product innovations and expanding their customer base across the globe. <p>Read More@<a title="https://www.insightslice.com/diagnostic-electrocardiograph-ecg-market" href="https://www.insightslice.com/diagnostic-electrocardiograph-ecg-market">https://www.insightslice.com/diagnostic-electrocardiograph-ecg-market</a></p> %20Market.webp)
Cyclospora is basically an intestinal ailment that is affected via the microscopic parasite termed as âCyclospora cayetanensisâ. Cyclospora Diagnostic Testing Market size on the basis of end-users spans commercial or private laboratories, hospitals, public health labs and physician offices. It is a single-celled coccidian parasitic pathogen that triggers intestinal infection that leads to diarrhea. When we look at it in the medical terms, this diarrheal infection is labeled as cyclospora infection (cyclosporiasis). It is known that this particular infection is usually spread and communicated via feces and ingestion of food and water infected with sporulated oocysts. Through studies, it has been found that people can be infected with Cyclospora by taking in food or water that is polluted and tainted with the parasite. Those people are at great risk for infection that stay in those countries or travel to regions where cyclosporiasis is quite prevalent. It is said that cyclospora diagnostic testing is not a regular laboratory test. It is only taken up following exact and particular requests from specialized physicians and doctors. Browse the Full Global Cyclospora Diagnostic Testing Market - Global Scenario, Industry Outlook, Analysis, Size, Trends and Forecast, 2014 To 2025 Report at - https://www.millioninsights.com/industry-reports/cyclospora-diagnostic-testing-market The most fundamental laboratory tests that are carried out for Cyclospora entail acid-fast staining and safranin staining. Even though there are a wide range of tests available, it is quite fascinating to know that there are no blood tests available for the treatment of Cyclospora infection. The prominent factors that are playing a major role in raising the demand for cyclospora diagnostic testing include augmented modernization, improvement in technology, and rising concerns for health related issues. Cyclospora Diagnostic Testing Market size on the basis of techniques used for diagnosis spans chromatography, diagnostic imaging, gel microdroplets, immunoassays, liposomal testing, differential light scattering, flow cytometry, monoclonal antibodies, and molecular diagnostics. Cyclospora Diagnostic Testing Market size on the basis of geography spans North America, Asia Pacific, Europe, and Rest of the World. As far as the geography is concerned, Asia Pacific is lately dominating the Cyclospora Diagnostic Testing market and it is also recognized as the largest market for these tests owing to more susceptive surrounding for infection. The data shows that this particular disease is quite prevalent in tropical and subtropical countries of Latin America and Asia. In addition, latest irregular occurrence of the infection has also been observed in temperate countries including the U.S., Canada, and Mexico. The data that has been revealed from the studies of the Centers for Disease Control and Prevention states that above 600 cases of Cyclospora infection were witnessed in 2013, because of the infection communicated via the means of packaged salad mix. The key players operating in the cyclospora diagnostic testing market include Roche Diagnostics, Siemens Healthcare, Diamedix Corporation, Hologic, Inc., DiaSorin S.p.A., Thermo Fisher Scientific, Inc., QIAGEN N.V., Wako Chemicals, Inc, Affymetrix, Inc., Nanogen, Inc., Ortho Clinical Diagnostics, Beckman Coulter, Inc., bioMerieux, Inc., and CEPHEID. Request a Free Sample Copy of Cyclospora Diagnostic Testing Market Report @ https://www.millioninsights.com/industry-reports/cyclospora-diagnostic-testing-market/request-sample Get in touch At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions. Contact Person: Ryan Manuel Research Support Specialist, USA Email: ryan@millioninsights.com Global Headquarters Million Insights Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States Phone: 1-408-610-2300 Email: sales@millioninsights.com Asia Pacific Million Insights Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India Phone: 91-20-65300184
A collective analysis on Hepatitis E Diagnostic Tests Market by Facto Market Insights provides a systematic analysis focused on emerging developments across different geographies affecting this vertical. The forecast involves key details on market size, market share, statistics, application, and revenue. Furthermore, this study provides a thorough competitive analysis based on business outlook that emphasizes the expansion strategies adopted by market majors. The global hepatitis e diagnostic tests market report delivers a detailed assessment of the hepatitis e diagnostic tests including enabling technologies, restraining factors, current market situation, market assumptions and a comprehensive overview, and growth opportunities of the market. Get Free Sample Report at https://www.factomarketinsights.com/sample/875 The report includes porter's Five Forces Analysis (potential entrants, industry competitors, suppliers, substitutes, and buyers), SWOT analysis and BPS analysis for every segment that provides crucial information for knowing the hepatitis e diagnostic tests market. Furthermore, the study explores and discusses the current landscape of the dynamic business sector along with present and potential impact of COVID-19 on the market for hepatitis e diagnostic tests. A comprehensive competitive overview, including market share and company profiles of key players operating in the global market, is covered in the report. Following are the major companies: Hoffmann-La Roche Ltd. Altona Diagnostics GmbH Mikrogen GmBH MP Biomedicals Pro - Diagnostic Bioprobes Fast-track diagnostics Ltd. Beijing Wantai Biological Pharmacy Enterprise Biokit S.A. Fortress Diagnostics Limited Primerdesign Following are the key segments covered in the report: By Test Type - ELISA HEV IgG Test kits - ELISA HEV IgM Test kits - RT-PCR Test kits - Others By End-User - Research Centers - Hospitals - Diagnostic Laboratories - Others Based on region, the global Hepatitis E Diagnostic Tests market is segmented into: North America (U.S. & Canada) Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Rest of Europe) Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand, and Rest of Asia Pacific) Latin America (Brazil, Mexico, and Rest of Latin America) Middle East & Africa (GCC, North Africa, South Africa, and Rest of Middle East & Africa) For Full Report with TOC Visit at https://www.factomarketinsights.com/report/875/hepatitis-e-diagnostic-tests-market The Following are the Key Features of Global Hepatitis E Diagnostic Tests Market Report: Market Overview, Industry Development, Market Maturity, PESTLE Analysis, Value Chain Analysis Growth Drivers and Barriers, Market Trends & Market Opportunities Porterâs Five Forces Analysis & Trade Analysis Market Forecast Analysis for 2020-2028 Market Segments by Geographies and Countries Market Segment Trend and Forecast Market Analysis and Recommendations Price Analysis Key Market Driving Factors Hepatitis E Diagnostic Tests Market Company Analysis: Company Market Share & Market Positioning, Company Profiling, Recent Industry Developments etc. Why Choose Facto Market Insights? A detailed set of market research reports with market share analysis, analysis of industry , product information, countries, market size, patterns, descriptions of business research, and much more. Market research reports to sectors, companies, and organizations to speed up the process of decision-making. 24/7 service for our customers online and offline. Our research specialists and industry experts ensure that we fulfill all your research requirements for business and industry - first and every time. For any Inquiry before buying this report visit at https://www.factomarketinsights.com/enquiry/875 About Us: Facto Market Insights is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on global industries, companies, products, and trends. Our in-house research experts have a wealth of knowledge in their respective domains. With Facto Market Research, you always have the choice of getting customized report free of cost (upto 10%). Our support team will help you customize the report and scope as per your business needs. This ensures that you are making the right purchase decision. Our clients list includes various Fortune 500 companies and leading advisory firms. Contact Us: Facto Market Insights 90 State Street, Albany, New York, USA 12207 +1 (518) 300-1215 Email:info@factomarketinsights.com Website: www.factomarketinsights.com
According to the new market research report âTransplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Bone Marrow), End User (Hospital) â Global Forecast to 2025âŗ, published by MarketsandMarketsâĸ, the Transplant Diagnostics Market is expected to reach USD 5.5 billion by 2025 from USD 3.6 billion in 2019, at a CAGR of 7.2%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=2531061 The demand for transplant diagnostic products is expected to grow mainly due to factors such as technological advancements, the growing number of diagnostic centers & hospitals, increased applications in patient profiling, and rising public-private investments to support product development. These factors have prompted market players to improve and strengthen their current manufacturing and distribution capabilities-especially in emerging markets, which are expected to witness the highest growth. Based on product, the reagents & consumables segment held the largest share of the market in 2019. On the basis of product, the Transplant Diagnostics Market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share of the global market in 2019. Factors such as the increasing patient emphasis on effective and early patient profiling during organ transplantation and the growing adoption of transplant diagnostic techniques in related research studies are driving the growth of this segment. Browse in-depth TOC on âTransplant Diagnostics Marketâ 153 â Tables 45 â Figures 227 â Pages Based on technology, the molecular assays segment is expected to witness the highest growth during the forecast period. On the basis of technology, the Transplant Diagnostics Market is segmented into molecular assay and non-molecular assay technology. The molecular assay technology segment is expected to register the highest CAGR during the forecast period. Factors such as its varied applications in patient profiling, rising public-private investments to support product development, and increasing clinical evidence of its efficacy are driving the growth of this segment. Based on the transplant type, the solid organ transplantation segment accounted for the largest share of this market in 2019. On the basis of transplant type, the market is categorized into solid organ, stem cell, and soft tissue transplantation. Solid organ transplantation accounted for the largest share of the Transplant Diagnostics Market in 2019. Supportive government regulations to increase organ donations across major healthcare markets, the rising number of chronic diseases/disorders leading to transplantation, and ongoing technological advancements in the field of transplant diagnostics are the key factors supporting the growth of the market for solid organ transplantation. Get 10% Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=2531061 North America accounted for the largest share of the Transplant Diagnostics Market in 2019 North America accounted for the largest share of the market in 2019, followed by Europe. This can primarily be attributed to the continuous commercialization of innovative transplant diagnostic products coupled with ongoing advancements in the field of genomics and proteomics, recent discovery genetic biomarkers & their clinical role in immunoassay testing, and the increasing prevalence of chronic and communicable diseases. Some of the prominent players in the Molecular Assay Technologies Market are Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific Inc. (US), and bioMÊrieux S.A. (France). Others are Immucor, Inc. (US), Illumina, Inc. (US), Luminex Corporation (US), CareDx (US), Becton, Dickinson and Company (US), Hologic (US), and GenDx (Netherlands).